MASTER SUM LTD v. ASIALAND LTD AND OTHERS
Court allowed final judgment on parts of the claims: HK$1,500,000 and HK$400,000 against Advance Pharmaceutical Company Limited and HK$137,750 against Loyal Advance Limited, because plaintiffs' evidence on those heads was prima facie sustainable and defendants' factual assertions were inadequate to defeat them at an Order 14 stage; the remainder of the plaintiffs' claims were left for trial with unconditional leave to defend; costs reserved and parties ordered to file submissions on costs.
- Citation
- MASTER SUM LTD v. ASIALAND LTD AND OTHERS
- Parties
- 1st Plaintiff: Lam Yiu Cho; 2nd Plaintiff: New Rainbow Overseas Incorporated; Plaintiff (hca 2339/2007): Master Sum Limited; 1st Defendant: Asialand Limited; 2nd Defendant: Cheng Chi Heng; 3rd Defendant: Advance Pharmaceutical Company Limited; 4th Defendant: Loyal Advance Limited
- Court
- Court of First Instance
- Jurisdiction
- Hong Kong
- Judgment Date
- 16 December 2008
- Case Number
- HCA2339/2007
- Procedural Posture
- Civil (contract) / Judgment on Summonses Arising From Order 14 Interlocutory Applications
- Outcome
- Final judgment entered in part for the plaintiffs; remainder of claims adjourned with unconditional leave to defend; costs reserved
- Legal Topics
- Implied Terms, Dividends and Accounts, Issue Estoppel, Consideration, Stakeholder/agency, Costs
- Source Language
- EN
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
Lam Yiu Cho
1st Plaintiff
New Rainbow Overseas Incorporated
2nd Plaintiff
Master Sum Limited
Plaintiff (hca 2339/2007)
Asialand Limited
1st Defendant
Cheng Chi Heng
2nd Defendant
Advance Pharmaceutical Company Limited
3rd Defendant
Loyal Advance Limited
4th Defendant
Procedural Posture
Civil (contract) / Judgment on Summonses Arising From Order 14 Interlocutory Applications
Legal Issues
- 1 Whether an implied term should be read into the share sale agreement requiring Asialand to assist in obtaining IRD confirmation
- 2 Whether the plaintiffs' claim against Asialand and guarantor Cheng was premature or should have been brought against the stakeholder
- 3 Whether Asialand breached clause 11 by failing to cause AP to issue accounts or declare dividends
Ratio Decidendi
Court allowed final judgment on parts of the claims: HK$1,500,000 and HK$400,000 against Advance Pharmaceutical Company Limited and HK$137,750 against Loyal Advance Limited, because plaintiffs' evidence on those heads was prima facie sustainable and defendants' factual assertions were inadequate to defeat them at an Order 14 stage; the remainder of the plaintiffs' claims were left for trial with unconditional leave to defend; costs reserved and parties ordered to file submissions on costs.
Court Disposition
Final judgment entered in part for the plaintiffs; remainder of claims adjourned with unconditional leave to defend; costs reserved
Orders
- Final judgment for HK$1,500,000 against Advance Pharmaceutical Company Limited
- Final judgment for HK$400,000 against Advance Pharmaceutical Company Limited
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment